{"transactions":[{"id":2308787,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":128429,"kind":"organization","name":"PF Equity Holdings 2 B.V.","position":1,"cik":"0001883111","reported_name":"PF Equity Holdings 2 B.V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T16:44:55.000Z","date":"2022-03-31","kind":"other","acquired":false,"shares":22032040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares transferred to its parent entity, Pfizer Inc., for no cash consideration."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares transferred to its parent entity, Pfizer Inc., for no cash consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares transferred to its parent entity, Pfizer Inc., for no cash consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001883111-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1883111/000188311122000001/primary_doc.xml","form_type":"4"}}]}